Which are the determinants of dyslipidemia in rheumatoid arthritis and does socioeconomic status matter in this context?

Journal of Rheumatology

Volumn 36, Issue 7, 2009, Pages 1357-1361

  Dessein, Patrick H ^a,c   Christian, Berenice F ^b   Solomon, Ahmed ^b  

^a Faculty of Health Sciences   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c NONE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CYCLOPHOSPHAMIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; LEFLUNOMIDE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHOTREXATE; MINOCYCLINE; PENICILLAMINE; PREDNISONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ABDOMINAL FAT; ADULT; AGED; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; DYSLIPIDEMIA; EDITORIAL; ENDOTHELIUM LESION; FEMALE; HUMAN; INFLAMMATION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRIVATE HOSPITAL; PUBLIC HEALTH SERVICE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SOCIOECONOMICS;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; DYSLIPIDEMIAS; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SOCIAL CLASS;

EID: 67650466985     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090288     Document Type: Editorial

References (19)

1. Kastelein JJP, van der Steeg WA, Holme I, et al. Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment. Circulation 2008;117:3002-9.
2. Dessein PH, Joffe BI. When is a patient with rheumatoid arthritis at risk for cardiovascular disease? J Rheumatol 2006;33:201-3.
3. Dessein PH, Joffe BI, Stanwix AE. Effects of disease modifying agents and dietary intervention on insulin resistance and dyslipidemia in inflammatory arthritis: a pilot study. Arthritis Res 2002;4:R12.
4. Park YB, Choi HK, Kim MY, et al. Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study. Am J Med 2002;113:188-93.
5. Gonzalez-Gay MA, De Matias JM, Gonzalez-Juanatey C, et al. Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol 2006;24:83-6.
6. Dessein PH, Joffe BI. Suppression of circulating interleukin-6 concentrations is associated with decreased endothelial activation in rheumatoid arthritis. Clin Exp Rheumatol 2006;24:161-7.
7. Carpentier YA, Scruel O. Changes in the concentration and composition of plasma lipoproteins during the acute phase response. Curr Opin Clin Nutr Metab Care 2002;5:153-8.
8. Nurmohamed MT. Atherogenic lipid profiles and its management in patients with rheumatoid arthritis. Vasc Health Risk Manag 2007;3:845-52.
9. Garcia-Gomez C, Nolla J, Gómez-Gerique J, Castro M, Pintó X. Conventional lipid profile and lipoprotein(a) concentrations in treated rheumatoid arthritis patients. J Rheumatol 2009;36:1365-70.
10. Lewington S, Whitlock G, Clarke R, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths. Lancet 2007;370:1829-39.
11. Cantin B, Gagnon F, Moorjani S, et al. Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study. J Am Coll Cardiol 1998;31:519-25.
12. del Rincon I, O'Leary DH, Haas RW, Escalante A. Effect of glucocorticoids on the arteries in rheumatoid arthritis. Arthritis Rheum 2004;50:3813-22.
13. Wolfe F, Michaud K. The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: A cohort and nested case-control analysis. Arthritis Rheum 2008;58:2612-21.
14. Linn S, Fulwood R, Carroll M, et al. Serum total cholesterol:HDL cholesterol ratios in US white and black adults by selected demographic and socioeconomic variables (HANES II). Am J Pub Health 1991;81:1038-43.
15. Marmot MG, Bosma H, Hemingway H, Brunner E, Stansfeld S. Contribution of job control and other risk factors to social variations in coronary heart disease incidence. Lancet 1997;350:235-9.
16. Solomon A, Christian BF, Dessein PH, Stanwix AE. The need for tighter rheumatoid arthritis control in a South African public health care center. Semin Arthritis Rheum 2005;35:122-31.
17. Beynen AC. Could chloroquine be of value in the treatment of hypercholesterolemia? Artery 1986;13:340-51.
18. del Rincon I, Freeman GL, Haas RW, O'Leary DH, Escalante A. Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum 2005;52:3413-23.
19. Maradit-Kremers H, Crowson CS, Therneau TM, Roger VL, Gabriel SE. High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients. A population-based cohort study. Arthritis Rheum 2008;58:2268-74.